Project Info.

Abstract

Background

Objective

Hypothesis

Procedures

Results

Future Work

Conclusions

Acknowledgements

References

1. Bach, J.F. Insulin-dependent diabetes mellitus as an autoimmue disease. Endocrine Rev. 15: 516-542.
2. Jani, D., Meena, L.S., Rizwan-ul-Haq, Q.M., Singh, Y., Sharma, A.K . and Tyagi, A.K. 2002. Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res.11: 447-454.
3. Le Gros, G., Ben-Sasson, S.Z., Seder, R., Finkelman, F.D. and Paul, W.E. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172: 921-929.
4. Ma, S., Huang, Y., Yin. Z., Menassa, R., Brandle, J.E. and Jevnikar, A.M. 2004. Induction of oral tolerance to prevent diabetes with transgenic plants require glutamic acid decarboxylase (GAD) and IL-4. Proc. Natl. Acad. Sci. USA 101: 5680-5685.
5. Ma, S., Huang, Y., David, A., Yin. Z., Mi, Q., Menassa, R., Brandle, J.E. and Jevnikar, A.M. 2005. Production of biologically active human interleukin-4 in transgenic tobacco and potato . Plant Biotech. J. 3: 309-318.
6. Rochen , M ., Rache, M. and Shevach, E.M. 1996. IL-4-induced immue deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 17: 225-231.
7. Slavin, A.J., Maron, R. and Weiner, H.L. 2001. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. International Immunol. 13: 825-833.
8. Zaccone, P., Phillips, J., Conget, I., Gomis, R., Haskins, K. , Minty, A., Bendtzen, K., Cooke, A. and Nicoletti, F. 1999. Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 48: 1522-1528.